Patent: 5,547,930
✉ Email this page to a colleague
Summary for Patent: 5,547,930
Title: | Asp.sup.B28 insulin crystals |
Abstract: | The present invention relates to insulin crystals comprising ASP.sup.B28 and protamine, and pharmaceutical preparations containing same. The crystals and preparations exhibit rapid onset and prolonged activity when administered in vivo. |
Inventor(s): | Balschmidt; Per (Esper.ae butted.rde, DK) |
Assignee: | Novo Nordisk A/S (Basgsvaerd, DK) |
Application Number: | 08/127,672 |
Patent Claims: | see list of patent claims |
Details for Patent 5,547,930
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Novo Nordisk Inc. | NOVOLOG MIX 70/30 | insulin aspart protamine and insulin aspart | Injectable Suspension | 021172 | 11/01/2001 | ⤷ Try a Trial | 2013-08-20 |
Novo Nordisk Inc. | NOVOLOG MIX 70/30 | insulin aspart protamine and insulin aspart | Injectable Suspension | 021172 | 05/03/2002 | ⤷ Try a Trial | 2013-08-20 |
Novo Nordisk Inc. | NOVOLOG MIX 50/50 | insulin aspart protamine and insulin aspart | Injectable Suspension | 021810 | 08/26/2008 | ⤷ Try a Trial | 2013-08-20 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,547,930
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 9500550 | ⤷ Try a Trial |
United States of America | 5840680 | ⤷ Try a Trial |
United States of America | 5834422 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |